Women, drugs and HIV

International Journal of Drug Policy

Volumn 26, Issue S1, 2015, Pages S16-S21

  Azim, Tasnim ^a   Bontell, Irene ^a,c   Strathdee, Steffanie A ^b  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Drug use; Females; Harm reduction; HIV; People who inject drugs; Sex work

Indexed keywords

BEHAVIOR THERAPY; CHILD CARE; COMORBIDITY; CONDOM USE; DRUG ABUSE; FEMALE; FEMALE CONDOM; HARM REDUCTION; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; INFECTION SENSITIVITY; INTRAVENOUS DRUG ABUSE; MIXED INFECTION; NOTE; PARTNER VIOLENCE; POPULATION RISK; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; PROSTITUTION; REPRODUCTIVE HEALTH; SEX DIFFERENCE; SEXUAL HARASSMENT; SOCIAL DISCRIMINATION; SOCIAL STIGMA; UNSAFE SEX; WOMEN'S HEALTH; COMPLICATION; HEALTH CARE DELIVERY; HIV INFECTIONS; MALE; RISK FACTOR; STATISTICS AND NUMERICAL DATA; SUBSTANCE ABUSE; SUBSTANCE-RELATED DISORDERS;

FEMALE; HARM REDUCTION; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; MALE; RISK FACTORS; SEX FACTORS; SOCIAL STIGMA; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE-RELATED DISORDERS; UNSAFE SEX;

EID: 84923381740     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2014.09.003     Document Type: Note

References (65)

1. Adimora A.A., Ramirez C., Auerbach J.D., Aral S.O., Hodder S., Wingood G., et al. Preventing HIV infection in women. Journal of Acquired Immune Deficiency Syndromes 2013, 63(Suppl. 2):S168-S173.
2. Adimora A.A., Schoenbach V.J., Taylor E.M., Khan M.R., Schwartz R.J. Concurrent partnerships, nonmonogamous partners, and substance use among women in the United States. American Journal of Public Health 2011, 101(1):128-136.
3. Altice F.L., Kamarulzaman A., Soriano V.V., Schechter M., Friedland G.H. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet 2010, 376(9738):367-387.
4. Asher A.K., Hahn J.A., Couture M.-C., Maher K., Page K. People who inject drugs, HIV risk, and HIV testing uptake in Sub-Saharan Africa. Journal of the Association of Nurses in AIDS Care 2013, 24(6):e35-e44.
5. Azim T., Chowdhury E.I., Reza M., Ahmed M., Uddin T., Khan R., et al. Vulnerability to HIV infection among sex worker and non-sex worker female injecting drug users in Dhaka, Bangladesh: Evidence from the baseline survey of a cohort study. Harm Reduction Journal 2006, 3:33.
6. Baral S., Todd C.S., Aumakhan B., Lloyd J., Delegchoimbol A., Sabin K. HIV among female sex workers in the Central Asian Republics, Afghanistan, and Mongolia: Contexts and convergence with drug use. Drug and Alcohol Dependence 2013, 132S:S13-S16.
7. Belani H., Chorba T., Fletcher F., Hennessey K., Kroeger K., Lansky A., et al. Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: Summary guidance from CDC and the US Department of Health and Human Services 2012, US Department of Health and Human Services, Centers for Disease Control and Prevention.
8. Binford M.C., Kahana S.Y., Altice F.L. A systematic review of antiretroviral adherence interventions for HIV-infected people who use drugs. Current HIV/AIDS Reports 2012, 9(4):287-312.
9. Braitstein P., Li K., Tyndall M., Spittal P., O'Shaughnessy M.V., Schilder A., et al. Sexual violence among a cohort of injection drug users. Social Science & Medicine 2003, 57(3):561-569.
10. Bruggmann P., Grebeley J. Prevention, treatment and care of hepatitis C virus infection among people who inject drugs. International Journal of Drug Policy 2014, 10.1016/j.drugpo.2014.08.014.
11. Cairns G., Baker A.C., Dedes N., Zakowicz A., West B. Treatment as prevention: Arriving at community consensus. Clinical Infectious Diseases 2014, 59(Suppl. 1):S35-S40.
12. Choopanya K., Martin M., Suntharasamai P., Sangkum U., Mock P.A., Leethochawalit M., et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): A randomised, double-blind, placebo-controlled phase 3 trial. Lancet 2013, 381:2083-2090.
13. Dargan P.I., Wood D.M. Recreational drug use in the Asia Pacific Region: Improvement in our understanding of the problem through the UNODC programmes. Journal of Medical Toxicology 2012, 8(3):295-299.
14. Deering K.N., Lyons T., Feng C.X., Nosyk B., Strathdee S., Montaner J.S.G., et al. Client demands for unsafe sex: The socioeconomic risk environment for HIV among street and off-street sex workers. Journal of Acquired Immune Deficiency Syndrome 2013, 63:522-531.
15. Degenhardt L., Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet 2012, 379(9810):55-70.
16. Degenhardt L., Mathers B., Vickerman P., Rhodes T., Latkin C., Hickman M. Prevention of HIV infection for people who inject drugs: Why individual, structural, and combination approaches are needed. Lancet 2010, 376(9737):285-301.
17. Des Jarlais D.C., Arasteh K., Perlis T., Hagan H., Abdul-Quader A., Heckathorn D.D., et al. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. AIDS 2007, 21(2):231-235.
18. Des Jarlais D.C., Feelemyer J.P., Modi S.N., Arasteh K., Hagan H. Are females who inject drugs at higher risk for HIV infection than males who inject drugs: An international systematic review of high seroprevalence areas. Drug and Alcohol Dependence 2012, 124:95-107.
19. Des Jarlais D.C., Feelemyer J.P., Modi S.N., Arasteh K., Mathers B.M., Degenhardt L., et al. Transitions from injection-drug-use-concentrated to self-sustaining heterosexual HIV epidemics: Patterns in the international data. PLoS ONE 2012, 7:e31227.
20. El-Bassel N., Shaw S.A., Dasgupta A., Strathdee S.A. Drug use as a driver of HIV risks: Re-emerging and emerging issues. Current Opinion in HIV and AIDS 2014, 9:150-155.
21. El-Bassel N., Shaw S.A., Dasgupta A., Strathdee S.A. People who inject drugs in intimate relationships: It takes two to combat HIV. Current HIV/AIDS Reports 2014, 11:45-51.
22. El-Bassel N., Terlikbaeva E., Pinkham S. HIV and women who use drugs: Double neglect, double risk. Lancet 2010, 376:312-314.
23. Ghimire B., Suguimoto S.P., Zamani S., Ono-Kihara M., Kihara M. Vulnerability to HIV infection among female drug users in Kathmandu Valley, Nepal: A cross-sectional study. BMC Public Health 2013, 13:1238.
24. Gilchrist G., Blazquez A., Torrens M. Psychiatric, behavioural and social risk factors for HIV infection among female drug users. AIDS and Behavior 2011, 15:1834-1843.
25. Guerrero E.G., Cederbaum J.A. Adoption and utilization of sexually transmitted infections testing in outpatient substance abuse treatment facilities serving high risk populations in the US. International Journal of Drug Policy 2011, 22(1):41-48.
26. Hammett T.M., Kling R., Van N.T.H., Son D.H., Binh K.T., Oanh K.T.H. HIV prevention interventions for female sexual partners of injection drug users in Hanoi, Vietnam: 24-Month evaluation results. AIDS and Behavior 2012, 16(5):1164-1172.
27. Iversen J., Grebely J., Topp L., Wand H., Dore G., Maher L. Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999-2011. Journal of Viral Hepatitis 2014, 21(3):198-207.
28. Lambdin B.H., Bruce R.D., Chang O., Nyandindi C., Sabuni N., Zamudio-Haas S., et al. Identifying programmatic gaps: Inequities in harm reduction service utilization among male and female drug users in Dar es Salaam, Tanzania. PLOS ONE 2013, 8:e67062.
29. Maehira Y., Chowdhury E.I., Reza M., Drahozal R., Gayen T.K., Masud I., et al. Factors associated with relapse into drug use among male and female attendees of a three-month drug detoxification-rehabilitation programme in Dhaka, Bangladesh: A prospective cohort study. Harm Reduction Journal 2013, 10:14.
30. Malta M., Magnanini M.F., Strathdee S., Bastos F. Adherence to antiretroviral therapy among HIV-infected drug users: A meta-analysis. AIDS and Behavior 2010, 14(4):731-747.
31. Malta M., Ralil da Costa M., Bastos F. The paradigm of universal access to HIV-treatment and human rights violation: How do we treat HIV-positive people who use drugs?. Current HIV/AIDS Reports 2014, 11(1):52-62.
32. Mantell J.E., West B.S., Sue K., Hoffman S., Exner T.M., Kelvin E., et al. Healthcare providers: A missing link in understanding acceptability of the female condom. AIDS Education and Prevention 2011, 23(1):65-77.
33. Marsh J.C., D'Aunno T.A., Smith B.D. Increasing access and providing social services to improve drug abuse treatment for women with children. Addiction 2000, 95(8):1237-1247.
34. Mathers B.M., Degenhardt L., Phillips B., Wiessing L., Hickman M., Strathdee S.A., et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 2008, 372:1733-1745.
35. McNairy M.L., El-Sadr W.M. A paradigm shift: Focus on the HIV prevention continuum. Clinical Infectious Diseases 2014, 59(Suppl. 1):S12-S15.
36. Meader N., Li R., Des Jarlais D., Pilling S. Psychosocial interventions for reducing injection and sexual risk behaviour for preventing HIV in drug users. Cochrane Database of Systematic Reviews 2010, CD007192.
37. Morris M.D., Lemus H., Wagner K.D., Martinez G., Lozada R., Gómez R.M.G., et al. Factors associated with pathways toward concurrent sex work and injection drug use among female sex workers who inject drugs in northern Mexico. Addiction 2013, 108:161-170.
38. Nelson P.K., Mathers B.M., Cowie B., Hagan H., Des Jarlais D., Horyniak D., et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: Results of systematic reviews. Lancet 2011, 378(9791):571-583.
39. Olsen A., Banwell C., Dance P., Maher L. Positive health beliefs and behaviours in the midst of difficult lives: Women who inject drugs. International Journal of Drug Policy 2012, 23(4):312-318.
40. Otiashvili D., Kirtadze I., O'Grady K.E., Zule W., Krupitsky E., Wechsberg W.M., et al. Access to treatment for substance-using women in the Republic of Georgia: Socio-cultural and structural barriers. International Journal of Drug Policy 2013, 24:566-572.
41. Panda S., Chatterjee A., Bhattacharya S., Manna B., Singh P., Sarkar S., et al. Transmission of HIV from injecting drug users to their wives in India. International Journal of STD & AIDS 2000, 11(7):468-473.
42. Pinkham S., Malinowska-Sempruch K. Women, harm reduction and HIV. Reproductive Health Matters 2008, 16(31):168-181.
43. Pinkham S., Stoicescu C., Myers B. Developing effective health interventions for women who inject drugs: Key areas and recommendations for program development and policy. Advances in Preventive Medicine 2012, 2012:10.
44. Radcliffe P. Motherhood, pregnancy, and the negotiation of identity: The moral career of drug treatment. Social Science & Medicine 2011, 72(6):984-991.
45. Roberts A., Mathers B.M., Degenhardt L. Women who inject drugs: A review of their risks, experiences and needs. Report by the reference group to the United Nations on HIV and injecting drug use: Secretariat of the reference group to the UN on HIV and Injecting, National Drug and Alcohol Research Centre (NDARC) 2010, University of New South Wales, Sydney, Australia. UNODC (Ed.).
46. Shannon K., Kerr T., Allinott S., Chettiar J., Shoveller J., Tyndall M.W. Social and structural violence and power relations in mitigating HIV risk of drug-using women in survival sex work. Social Science & Medicine 2008, 66:911-921.
47. Shoptaw S., Montgomery B., Williams C.T., El-Bassel N., Aramrattana A., Metsch L., et al. Not just the needle: The state of HIV-prevention science among substance users and future directions. Journal of Acquired Immune Deficiency Syndromes 2013, 63:S174-S178.
48. Sidibé M., Zuniga J.M., Montaner J. Leveraging HIV treatment to end AIDS, stop new HIV infections, and avoid the cost of inaction. Clinical Infectious Diseases 2014, 59(Suppl. 1):S3-S6.
49. Simmons J., Rajan S., McMahon J.M. Retrospective accounts of injection initiation in intimate partnerships. International Journal of Drug Policy 2012, 23(4):303-311.
50. Simpson M., McNulty J. Different needs: Women's drug use and treatment in the UK. International Journal of Drug Policy 2008, 19(2):169-175.
51. Sordo L., Chahua M., Bravo M.J., Barrio G., Brugal M.T., Domingo-Salvany A., et al. Depression among regular heroin users: The influence of gender. Addictive Behaviors 2012, 37(1):148-152.
52. Strathdee S.A., Abramovitz D., Lozada R., Martinez G., Rangel M.G., Vera A., et al. Reductions in HIV/STI incidence and sharing of injection equipment among female sex workers who inject drugs: Results from a randomized controlled trial. PLOS ONE 2013, 8:e65812.
53. Strathdee S.A., Hallett T.B., Bobrova N., Rhodes T., Booth R.E., Abdool R., et al. HIV and risk environment for injecting drug users: The past, present, and future. Lancet 2010, 376(9737):268-284.
54. Strathdee S.A., Philbin M.M., Semple S.J., Pu M., Orozovich P., Martinez G., et al. Correlates of injection drug use among female sex workers in two Mexico - U.S. border cities. Drug and Alcohol Dependence 2008, 92:132-140.
55. Strathdee S.A., Stockman J.K. Epidemiology of HIV among injecting and non-injecting drug users: Current trends and implications for interventions. Current HIV/AIDS Reports 2010, 7(2):99-106.
56. Suthar A.B., Ford N., Bachanas P.J., Wong V.J., Rajan J.S., Saltzman A.K., et al. Towards universal voluntary HIV testing and counselling: A systematic review and meta-analysis of community-based approaches. PLOS Medicine 2013, 10.
57. Taplin S., Mattick R.P. Supervised contact visits: Results from a study of women in drug treatment with children in care. Children and Youth Services Review 2014, 39(0):65-72.
58. Tross S., Campbell A.N.C., Cohen L.R., Calsyn D., Pavlicova M., Miele G., et al. Effectiveness of HIV/STD sexual risk reduction groups for women in substance abuse treatment programs: Results of a NIDA clinical trials network trial. Journal of Acquired Immune Deficiency Syndrome 2008, 48(5):581-589.
59. UNODC Women for women: Gender sensitive programmes for highly vulnerable women and girls in Ukraine 2013, UNODC.
60. UNODC A scientific statement from the UNODC scientific consultation on science addressing drugs and HIV: State of the art of harm reduction 2014, UNODC, Vienna.
61. UNODC, icddrb Female drug users and female regular partners of male drug users in Bangladesh - A report 2010, UNODC and icddr,b.
62. Wechsberg W.M., Jones H.E., Zule W.A., Myers B.J., Browne F.A., Kaufman M.R., et al. Methamphetamine (tik) use and its association with condom use among out-of-school females in Cape Town, South Africa. American Journal of Drug and Alcohol Abuse 2010, 36(4):208-213.
63. Williams M.L., McCurdy S.A., Atkinson J.S., Kilonzo G.P., Leshabari M.T., Ross M.W. Differences in HIV risk behaviors by gender in a sample of Tanzanian injection drug users. AIDS and Behavior 2007, 11(1):137-144.
64. Wolfe D., Carrieri M.P., Shepard D. Treatment and care for injecting drug users with HIV infection: A review of barriers and ways forward. Lancet 2010, 376(9738):355-366.
65. World Health Organization WHO, UNODC, UNAIDS technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users - 2012 revision. 2012.